MedTrace Logo

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

NCT06360133 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2024-11-20

No results posted yet for this study

Summary

This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.

Conditions

  • Dry Eye

Interventions

DRUG

VVN001 Ophthalmic Solution, 5%

VVN001 Ophthalmic Solution, 5%

DRUG

VVN001 Ophthalmic Solution, Vehicle

VVN001 Ophthalmic Solution, Vehicle

Sponsors & Collaborators

  • VivaVision Biotech, Inc

    lead INDUSTRY

Principal Investigators

  • Xinghuai Sun · Eye & ENT Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360133 on ClinicalTrials.gov